The melanocortin melanocyte-stimulating hormone/adrenocorticotropin4-10 decreases body fat in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 3, 2001, Pages 1144-1148

  Fehm, Horst L ^a   Smolnik, Rüdiger ^a   Kern, Werner ^a   McGregor, Gerard P ^a   Bickel, Ulrich ^a   Born, Jan ^b,c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c Clinical Neuroendocrinology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; INTERMEDIN; MELANOCORTIN;

ACTION POTENTIAL; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROL SYSTEM; ENERGY EXPENDITURE; FEMALE; HUMAN; LIGAND BINDING; MALE; NEUROTRANSMITTER RELEASE; OBESITY; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADRENOCORTICOTROPIC HORMONE; ADULT; ALPHA-MSH; BODY COMPOSITION; HUMANS; INSULIN; LEPTIN; MELANOCYTE-STIMULATING HORMONES; PEPTIDE FRAGMENTS; PLACEBOS; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, PEPTIDE; THYROID HORMONES; THYROTROPIN; WEIGHT LOSS;

ANIMALIA;

EID: 0035044397     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.3.1144     Document Type: Article

References (43)

1. Identification of targets of leptin action in rat hypothalamus
2. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization
3. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats
4. Insulin in the brain: A hormonal regulator of energy balance
5. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression
6. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans
7. Signals that regulate food intake and energy homeostasis
8. Obesity and the hypothalamus: Novel peptides for new pathways
9. Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss
10. The how and Y of eating
11. Molecular characterization of the mouse agouti locus
12. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor
13. From the agouti protein to POMC-100 years of fat blonde mice
14. Targeted disruption of the melanocortin-4 receptor results in obesity, in mice
15. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences
16. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans
17. Identification and functional analysis of novel human melanocortin-4 receptor variants
18. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
19. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin
20. As obesity rates rise, experts struggle to explain why
21. Environmental contributions to the obesity epidemic
22. Eating disorders: Progress and problems
23. Differential effects of melanocortin peptides on neural melanocortin receptors
24. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
25. The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of α-MSH
26. α-Melanocyte stimulating hormone: Immunohistochemical identification and mapping in neurons of rat brain
27. α-MSH-like peptides from the rat hypothalamus and pituitary: Differences in the degree of N-acetylation
28. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain
29. Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey
30. Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat
31. Penetration of DGAVP (Org 5667) across the blood-brain barrier in human subjects
32. Uptake of exogenous proteins in mouse olfactory cells
33. The behaviorally active peptide ACTH 4-10; Measurement in plasma and pharmacokinetics in man
34. Neurokinin-immunoreactivity in human neuroblastomas. Evidence for selective expression of preprotachykinin (PPT) II gene
35. Bioelectrical impedance analysis in body composition measurement: National Institutes of Health technology assessment conference statement
36. Assessment of fat-free mass using bioelectrical impedance measurements of the human body
37. Usefulness of bioelectric impedance and skinfold measurements in predicting fat-free mass derived from total body potassium in children
38. A nose-brain pathway for psychotropic peptides: Evidence from a brain evoked potential study with cholecystokinin
39. Central nervous effects of intranasally administered insulin during euglycemia in humans
40. Melanin-concentrating hormone: A functional melanocortin antagonist in the hypothalamus
41. Functional interactions between melanin-concentrating hormone, neuropeptide Y, and anorectic neuropeptides in the rat hypothalamus
42. Brain potentials and attention after acute and subchronic intranasal administration of ACTH 4-10 and desacetyl-α-MSH in humans
43. Central actions of ACTH and related peptides